InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,332.00
(
0.63%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.58
(
-0.15%
)
Bitcoin
61,180.00
(
0.00%
)
Post# of 35633
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sojourner

Send PM Follow Ignore
Followers 50
Posts 8785
Boards Moderated 0
Alias Born 09/21/2004

sojourner

Re: bbhuey post# 24973

Sunday, 12/14/2008 12:24:04 PM

Sunday, December 14, 2008 12:24:04 PM

Post# of 35633
bbhuey: Good question. FDA policy disallows official FDA publication of pending 510(k) applications. Not only that, only SE approvals are published; NSEs (i.e., disapprovals) are not revealed. However, it's likely CSMG would have notified shareholders of additional FDA filing(s) as happened pursuant to LTC's first 510(k).

These are my opinions and sentiments only. Take them for what they're worth. Do your DD. Buying stocks is risky!

"If we could sell our experiences for what they cost us, we'd all be millionaires." -Abigail van Buren (a/k/a Dear Abby)

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up